News from upsher-smith laboratories, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 20, 2017, 08:41 ET Japan's Sawai Pharmaceutical to Acquire the Generics Business of U.S. Upsher-Smith Laboratories

Sawai Pharmaceutical Co. Ltd. ("Sawai"), a leading Japanese generic pharmaceuticals manufacturer, and Upsher-Smith Laboratories, Inc.,...

Mar 30, 2017, 09:00 ET FDA Approves Expanded Indication for Qudexy® XR (topiramate) Extended-Release Capsules to Include Prophylaxis of Migraine Headache in Adults and Adolescents

Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that it has received U.S. Food and Drug Administration (FDA) final approval of two...

Mar 22, 2017, 09:13 ET Upsher-Smith Announces The Launch Of Generic Clomipramine

Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced the U.S. launch of Clomipramine Hydrochloride Capsules* USP, 25 mg, 50 mg and 75 mg,...

Mar 17, 2017, 10:56 ET Upsher-Smith Enters Agreement To Expand Marketing And Distribution Of Generic Products For U.S. Market

Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that it has entered into an exclusive agreement with an emerging pharmaceutical...

Feb 15, 2017, 08:00 ET Upsher-Smith Partners With The National Alliance Of State Pharmacy Associations (NASPA) To Honor 43 U.S. Pharmacists

Upsher-Smith Laboratories, Inc. (Upsher-Smith) and the National Alliance of State Pharmacy Associations (NASPA) are proud to recognize 43 pharmacists ...

Dec 19, 2016, 10:56 ET Upsher-Smith Divests AmLactin® Brand Family

Upsher-Smith Laboratories, Inc. (Upsher-Smith), a Minnesota-based pharmaceutical company today announced that it has entered into a definitive...

Nov 07, 2016, 09:00 ET Upsher-Smith Continues To Expand Generic Product Portfolio

Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that it has entered into an exclusive agreement with Bluepharma S.A. to develop and...

Nov 03, 2016, 09:00 ET Upsher-Smith Supports Events Across the Country in Recognition of National Epilepsy Awareness Month

In recognition of National Epilepsy Awareness Month (NEAM), Upsher-Smith Laboratories, Inc. (Upsher-Smith) is proud to highlight the following events ...

Oct 28, 2016, 09:00 ET Upsher-Smith Presents Data Characterizing The Pharmacokinetics And Safety/Tolerability Of Investigational Midazolam Nasal Spray (USL261) In Pediatric Participants With Epilepsy

Upsher-Smith Laboratories, Inc., today announced that data from a Phase 1 study of USL261 (midazolam nasal spray) in pediatric participants with...

Oct 18, 2016, 09:00 ET Upsher-Smith Acquires 20 Generic Drug Products

Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that it has acquired more than 20 US generic products from Sandoz, Inc. for an upfront ...

Oct 17, 2016, 10:26 ET Randy McDonough Named 2016 Willard B. Simmons Independent Pharmacist Of The Year By NCPA

Upsher-Smith Laboratories, Inc. (Upsher-Smith) is pleased to recognize Iowa pharmacist Randy McDonough, RPh, this year's recipient of the National...

Sep 27, 2016, 09:00 ET Upsher-Smith Enters into Exclusive development and Distribution Agreement with Pharmathen S.A.

Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that it has entered into an exclusive agreement with Pharmathen S.A. to develop and...

Sep 08, 2016, 09:00 ET Upsher-Smith Launches "It's That Simple" Program For Qudexy® XR (topiramate) Extended-Release Capsules

Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced the availability of the "It's That Simple" program - a new savings and support...

Aug 25, 2016, 11:29 ET Upsher-Smith Enters Into Exclusive Marketing and Distribution Agreement with Emerging Pharmaceutical Company

Upsher-Smith Laboratories, Inc. (Upsher-Smith) announced that it has entered into an exclusive agreement with an emerging pharmaceutical company to...

Jun 30, 2016, 09:00 ET Upsher-Smith Wins Prestigious DIANA Award From Healthcare Distribution Alliance

Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that it has been honored with a Distribution Industry Award for Notable Achievement in ...

Jun 09, 2016, 04:57 ET Upsher-Smith Granted Tentative FDA Approval For Qudexy® XR (topiramate) Extended-Release Capsules For Prophylaxis Of Migraine Headache In Adults

Upsher-Smith Laboratories, Inc. (Upsher-Smith) announced that the U.S. Food and Drug Administration (FDA) has granted tentative approval for its...

May 16, 2016, 09:00 ET Upsher-Smith Announces Start Of First In Human Clinical Trial In Oncology With Novel CXCR4 Antagonist USL311

Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that it has commenced the first clinical study of its novel small molecule CXCR4...

Apr 25, 2016, 09:05 ET ANDROXY™ (Fluoxymesterone Tablets, USP) CIII Available Exclusively Through Upsher-Smith

Upsher-Smith Laboratories, Inc. (Upsher-Smith) announced that ANDROXY™ (Fluoxymesterone Tablets, USP) CIII are available for prescription....

Apr 18, 2016, 09:00 ET Research Presented At 68th Annual Meeting Of The American Academy of Neurology Estimates That More Than One Million U.S. Emergency Department Visits Annually Are Related To Epilepsy

A cohort study using 2008-2011 data from the National Hospital Ambulatory Medical Care Survey found that seizure emergencies accounted for more than...

Feb 11, 2016, 09:00 ET Upsher-Smith Recognizes Outstanding Achievements Of 43 U.S. Pharmacists

Upsher-Smith Laboratories, Inc. (Upsher-Smith) has partnered with the National Alliance of State Pharmacy Associations (NASPA) to honor 43...

Jan 20, 2016, 09:17 ET Upsher-Smith And Saniona Sign Collaboration Agreement For Development Of Novel Therapeutics For Neurological Disorders

Upsher-Smith Laboratories, Inc. (Upsher-Smith), through its wholly-owned subsidiary Proximagen Ltd., and Saniona, a leading biotech company in the...

Dec 07, 2015, 09:00 ET Seizure Clusters Significantly Impact Quality Of Life For Patients And Their Caregivers, According To A Landmark Survey Conducted By Harris Poll

Results from a nationwide survey that measured the physical and emotional impact of seizure clusters, a seizure pattern experienced by some patients...

Dec 07, 2015, 09:00 ET Upsher-Smith Presents Data Evaluating PK, PD And Tolerability Of Investigational Midazolam Nasal Spray In Healthy Geriatric And Non-Geriatric Adults

Upsher-Smith Laboratories, Inc., today announced that Phase 1 clinical trial data from USL261 (midazolam nasal spray) in healthy geriatric and...

Dec 01, 2015, 01:15 ET Roche And Upsher-Smith Announce License Agreement To Develop Novel VAP-1 Inhibitor

Roche and Upsher-Smith Laboratories, Inc. (Upsher-Smith), through its wholly-owned UK subsidiary Proximagen Ltd., today announced a worldwide...

Nov 23, 2015, 09:00 ET Upsher-Smith To Present New Data On Qudexy® XR (topiramate) Extended-Release Capsules And USL261 (Investigational Intranasal Midazolam)

Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that it will present nine posters at the 69th Annual Meeting of the American Epilepsy...